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ABSTRACT 
Objective: L-asparaginase (L-asp) is a vital enzyme used as a therapeutic agent in combination with other drugs in the treatment of acute 
lymphoma, melanosarcoma and lymphocytic leukemia. Immobilization of enzymes through loading on nanoemulsion (NE) results in some 
advantages such as enhancing their stability and increasing their resistance to proteases. Aim of the present study is to formulate L-asp loaded 
nanoemulsion to enhance its efficiency and thermal stability.  
Methods: Nanoemulsion loaded with L-asp crude extract (specific activity 13.23U/mg protein) was prepared employing oleic acid as oil, tween 
20/tween 80 as surfactants and propylene glycol (PG) as co-surfactant. L-asp loaded NE underwent several thermodynamic stability studies and the 
optimized formulae were further examined for their biochemical properties and thermal stability.  
Results The developed formulations were spherical in shape and their sizes were in the nanometric dimensions with negatively charged zeta 
potential values. Upon comparing the enzyme activity of L-asp loaded NE employing tween 20 (F1) or tween80 (F4) at different concentrations, the 
results revealed that F4 NE showed higher enzymatic activity [323 U/ml] compared to F1 NE [197 U/ml] at the same concentration. The nanosized 
immobilized L-asp was more stable in the pH range from 8 to 8.5 as compared to free L-asp. The immobilized enzyme preserved about 59.11% of its 
residual activity at 50 °C; while free L-asp preserved about 33.84%.  
Conclusion: In the view of these results, NE composed of oleic acid, tween 80 and PG represents a promising dosage form for enhancing the activity 
and stability of Streptomyces griseoplanus L-asp. 
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INTRODUCTION 
L-asparaginase (L-asparagine aminohydrolase, EC 3.5.1.1) (L-asp) is 
a vital enzyme used as a therapeutic agent in the treatment of acute 
lymphoma in children, melanosarcoma, acute myelocytic leukemia, 
chronic lymphocytic leukemia, lymphosarcoma, reticulosarcoma, 
and Hodgkin disease [1, 2]. It has an antioxidant property [3]. L-asp 
is used in the manufacture of food. It can efficiently decrease the 
level of acrylamide up to 90% in the preparation of starchy fried 
foods without any alter in the final form of the product [4]. 
L-asp circulates in the blood system for a short time before it is 
broken down by proteases. This causes a limitation in its 
effectiveness. Thus, L-asp was usually chemically modified or 
physically embedded with biocompatible polymers in order to 
reduce the immunological response, prolong its action time and 
improve drug effects in blood. Preparation of an immobilized 
enzyme may result in a reduction in toxicity. Furthermore, 
immobilized enzyme significantly enhances the resistance to 
proteolysis with respect to native L-asp [5]. 
Recently, the world of science has been altered with the evolution of 
nanotechnology. Nanotechnology has helped scientists to think more 
accurately and to develop better treatments. Nanotechnology can be 
defined as the science which deals with the particles of nanoscale 
sizes. The use of nanotechnology has been amplified in the last couple 
of years [6]. Different kinds of pharmaceuticals have been 
technologically advanced by employing different nanoparticles such as 
nanoemulsions, nanosuspensions, nanovesicles [7, 8], nanospheres 
[9], lipid nanoparticles [10], nanotubes and nanoshells [11]. 
Nanoemulsions are water-in-oil or oil-in-water formulations 
prepared by blending oil, water, surfactant and cosurfactant in the 
right proportion by using high-stress mechanical extrusion [12]. 
They are non-equilibrium systems with a spontaneous tendency to 
phase separation (substantial separation of the dispersed phase 
from the dispersant). Nevertheless, they may have long kinetic 
stability and are reasonably resistant to creaming or sedimentation 
as well as to flocculation [13]. This process yields uniform droplets 
ranging in size from 20-200 nm in diameter [14]. These discrete 
droplets owing to their size selectively fuse with bacterial cell walls 
by destabilizing their lipid envelope [12]. Due to this property, they 
are included in the Generally Regarded as Safe (GRAS) list and are 
approved for various human applications [15]. 
A nanoemulsion system is a good applicant for oral delivery of poorly 
water-soluble drugs due of its capability to enhance drug 
solubilization and thus improves its absorption in the gastrointestinal 
tract (GIT), because of the permeability changes induced by the 
surfactant. NEs are one of the promising systems that are prepared to 
enhance the bioavailability of poorly soluble drugs [14]. They have 
been utilized for delivery of hydrophilic, lipophilic and amphiphilic 
drugs through different routes of administration, such as oral, 
transdermal, ophthalmic and parenteral routes [4]. They can be 
formed on a large scale without performing high energy 
homogenization [14]. NEs are non-equilibrium systems having a 
tendency to phase separation. However, they have long kinetic 
stability and they resist sedimentation, creaming and flocculation [13].  
Immobilization of enzymes through loading on nanoemulsion can result 
in some advantages, such as enhancing their stability and their 
resistance to proteases. The aim of the present work is to formulate and 
investigate L-asp loaded nanoemulsion aiming at enhancing its activity 
using non-irritant and pharmaceutically acceptable ingredients.  
MATERIALS AND METHODS 
Materials 
Oleic acid was purchased from Alpha Chemika, India. Tween® 20 
(extra-pure, 99%) was obtained from VWR International, France. 
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Tween® 80 (extra-pure, 99%) was procured from Riedel-de Haën, 
Italy. Propylene glycol (PG) was purchased from BDH Laboratory, UK. 
Methanol was procured from Fisher Scientific, UK. All chemicals are 
nonirritant and fall under generally regarded as safe (GRAS) category. 
Microorganism and cultivation conditions 
The actinomycetes strain Streptomyces griseoplanus strain isolated from 
some soil samples was used in the present study. The actinomycetes 
isolate (Streptomyces griseoplanus strain) was identified by16S rDNA, as 
described by El-Hadi et al. (2019) [16]. The organism was maintained on 
starch casein agar slants (contained in g/l: starch, 10; casein, 0.3; KNO3, 
2; NaCl, 2; K2HPO4, 2; MgSO4.7H2O, 0.05; CaCO3, 0.02; FeSO4. 7H2O, 0.01; 
agar 25; pH 7) and incubated for 7–10 d at 28 °C, and then maintained at 
4 °C until further use. Inoculum was prepared from the 7-day-old culture 
of the strain. Adequate amounts of sterilized water were added to the 
optimum growth slants. Sterilized inoculating needle was used for gentle 
scratching of the cells. The tube was lightly shaken and transferred to 50 
ml of sterilized inoculum medium. The inoculated flasks were incubated 
in the shaker at 28 °C while shaking at 180 rpm for 10 d [16]. 
Crude enzyme extraction  
According to our optimized protocol for the overproduction of 
recombinant protein [17], the crude enzyme from the fermented 
substrate was extracted using 0.1M phosphate buffer (pH 8). After 
mixing the fermented substrate with 41 ml of buffer, the flasks were 
kept on a rotary shaker at 150 rpm for 30 min. The slurry was 
centrifuged at 10,000 rpm for about 10 min at 4 °C in a cooling 
centrifuge. Supernatant was collected and used for enzyme assay. 
Assay of L-asp activity 
L-asp activity was determined by Nessler’s method. The cultures 
present in starch casein broth were centrifuged at 8000 rpm for 30 
min and the resultant supernatant, that is, the crude extract was used 
to determine the L-asp activity. Reaction was started by adding 0.5 ml 
of crude cell-free extract into 0.5 ml of 0.04 M L-asparagine solution 
and 0.5 ml of 0.05 M Tris HCL buffer pH 8 and incubated at 37 ∘C for 30 
min in the water bath. The reaction was stopped by addition of 0.5 ml 
of 1.5 M trichloroacetic acid (TCA). Precipitated proteins were 
removed by centrifugation at 8000 rpm for 15 min at 4 °C, and the 
ammonia released was determined spectrophotometrically at 425 nm. 
Tubes kept at zero-time incubation served as control. Enzyme activity 
was determined based on the liberation of ammonia calculated with 
reference to a standard curve of ammonium sulphate. In the 
concentration range of 0.1 ml of supernatant was added to 3.75 ml of 
distilled water, followed by the addition of 0.2 ml of Nessler’s reagent 
and was incubated at room temperature for 10 min after which the 
absorbance was taken at 425 nm. One unit (U) of L-asp is defined as 
the amount of enzyme which catalyzed the formation of 1  mole of 
ammonia from L-asparagine per minute under the standard assay 
conditions [3, 18]. 
Construction of pseudoternary phase diagrams 
Tween20 and Tween80 were selected to prepare nanoemulsion 
because of their high hydrophilic-lipophilic balance (HLB) value, 
which forms oil-in-water emulsion [19]. Non-ionic surfactants act by 
stabilizing emulsions by creating a steric barrier via the bulky 
molecular groups, which are directed to the continuous medium [20]. 
Oleic acid was selected as oil, while propylene glycol (PG) was selected 
as co-surfactant. Aqueous titration method reported by [21] was 
employed to establish pseudoternary phase diagrams. A series of 
oil/Smix mixtures were prepared at different combinations (1:9, 2:8, 
3:7, 4;6, 5:5, 6:4, 7:3, 8:2 and 9:1) and titrated with water to determine 
the nanoemulsion region. The total water consumed was recorded in 
terms of w/w. Visual observation was done after each addition of 
aqueous. The percentages of oil, Smix and water were plotted on 
ternary phase diagrams where one axis represents the Smix, the second 
represents the aqueous phase and the third represents the oil phase. 
The endpoint of titration was recorded at the point at which the 
mixture appeared viscous, turbid or separated. The phase diagram 
was plotted employing ternary plot software (Sigma Plot for windows, 
version 11.0, Systat Software, Inc., Ca, USA). 
Preparation of L-asp loaded nanoemulsion 
A defined amount of the enzyme was mixed with the required 
amounts of surfactant. Oil and co-surfactant were added at a fixed 
ratio. Bi-distilled water was then added gradually. This was followed 
by vortexing, which required for dissolving the enzyme completely 
in nanoemulsion system till the formation of a transparent and 
homogenous nanoemulsion formulation. The developed 
nanoemulsions were stored at room temperature till further 
processing. A number of nanoemulsions with different compositions 
were selected from the pseudoternary phase diagrams and were 
subjected to further studies. The composition of selected 
formulations is given in table 1. 
Thermodynamic stability testing of the developed nanoemulsions 
The thermostability differentiates nano/microemulsions from 
emulsions, which will eventually phase separate [22]. The selected 
nanoemulsions were subjected to the following thermodynamic 
stability studies in order to find out the stable nanoemulsion and to 
discard the unstable one. 
Centrifugation studies 
Nanoemulsions were subjected to centrifugation studies for 30 min. 
at 5,000 rpm. The stable formulations did not show any phase 
separation or turbidity. 
Heating cooling cycle 
Six cycles between refrigerator temperature (4 °C) and 40 °C with 
storage of 48 h were performed. The formulations that did not show 
any phase separations, creaming or cracking were subjected to 
freeze-thaw cycle study. 
Freeze-thaw cycle 
Nanoemulsions were kept at-20 °C in a deep freezer for 24 h. This 
was followed by transferring the nanoemulsions to room 
temperature (25±2 °C) to be kept there for another 24 h. This cycle 
was repeated three times. The formulations which were stable after 
finishing the three freeze-thaw cycles were subjected to 
dispersibility study. 
 
Table 1: Composition, thermodynamic stability and dispersibility studies of the developed L-Asp NE formulations 




Water (%) Heat/Cool Centrifugation Freeze Dispersibility 
Tw20 Tw80 Grade Result 
F1 10 40 -- 40 10 √ √ √ A Passed 
F2 20 35 -- 35 10 √ √ √ D Failed 
F3 30 30 -- 30 10 √ √ √ E Failed 
F4 10 -- 40 40 10 √ √ √ A Passed 
F5 20 -- 35 35 10 √ √ √ D Failed 
F6 30 -- 30 30 10 √ √ √ E Failed 
*All formulations were prepared at Smix ratio of 1:1.  
 
Dispersibility study 
When a nanoemulsion formulation is diluted with GIT fluids, phase 
separation may occur, leading to precipitation of a poorly soluble 
drug. For parenteral and oral NE this dilution process will result in 
desorption of surfactant located at the globule interface. In the 
present study, the dispersion medium used was distilled water. An 
amount of 1 ml of each selected NE formulation was added to 500 ml 
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of distilled water in a glass beaker with gentle agitation by placing it 
on a hotplate magnetic stirrer, with temperature adjusted to 37±0.5 
°C, stirred at 50 rpm. The self-emulsification efficiency of each 
formulation was visually assessed using the following grading 
system [23]: 
Grade A: Forms NE rapidly (within 1 min), with a clear appearance. 
Grade B: Forms NE rapidly with a less clear emulsion. 
Grade C: Forms milky emulsion within 2 min. 
Grade D: Forms grayish-white emulsion with some oily appearance 
(longer than 2 min). 
Grade E: Poor or minimal emulsification having large oil globules on 
the surface. 
Formulations that passed dispersibility tests in Grade A and B were 
chosen for further studies. 
Characterization of L-Asp loaded nanoemulsion 
Transmission electron microscopy (TEM) 
The morphology of the developed L-asparaginase NE was 
investigated using TEM. A drop of the NE formulation was placed on 
the grid. This was followed by a drop of phosphotungstic acid (l %). 
The grid was then tapped on a filter paper and the samples were 
then examined by TEM (JEOL Co., JEM-2100, Tokyo, Japan) at 
different magnification powers. 
Droplet size 
The droplet size, size distribution and polydispersity index (PDI) of 
the developed formulations were determined by dynamic light 
employing scattering Zeta-Sizer (Malvern, Nano Series 2590, 
Malvern Instruments, Ltd., UK). 1 ml of the formulation was taken in 
a volumetric flask and diluted with 50 ml bi-distilled water. The 
droplet size of the resultant emulsions was then determined. All 
measurements were performed in triplicate. Data were represented 
as droplet size (mean±SD). 
Zeta potential (ZP) 
The ZP of the developed nanoemulsions was determined by laser 
diffraction analysis employing Zeta-Sizer (Malvern, Nano Series 
2,590, Malvern Instruments, Ltd., UK). The samples were diluted at a 
ratio of 1:50 (v/v) with bi-distilled water. All measurements were 
performed in triplicate. Data were represented as droplet size 
(mean±SD). 
Optimization of enzyme loading 
Two L-asp loaded NE formulations, namely F1 and F4 were selected 
for further investigations owing to their highest stability. In order to 
investigate the optimal enzyme activity, these NEs were loaded with 
four different concentrations of protein, namely; 5, 7.5, 10 and 15% 
(v/v). These NEs were prepared according to the procedure 
previously mentioned.  
Optimum pH and temperature studies 
The optimum pH was determined by measuring enzymatic activity 
employing different buffers with various pH values as: 0.1 M citrate–
phosphate buffer (pH 5.0–7.0) and 0.1 M Tris-HCl buffer (pH 8-9). 
Optimum temperature was assayed by measuring activity with 
varying temperatures ranging from 30 to 55 °C for 30 min using 
2.0% L-asp as a substrate at the optimum pH values.  
Determination of activation energy (Ea) 
The activation energy was determined employing the slope of a linear 
plot of the log of the enzyme activity (v) versus 1/T. The enzyme 
activity (v) was expressed in U (mg protein)–1, the temperature (T) in 
Kelvin (K), the gas constant (R) = 1.987 cal K–1 mol–1 and the activation 
energy (Ea) was expressed in Kcal mol–1 [24]. 
Thermal stability of L-asp nanoemulsion 
The thermostability of the nano-immobilized enzyme was determined 
by incubating the biocatalyst at 30-60 °C for 15, 30, and 60 min in a 
water bath. Residual activity in samples without incubation was taken 
as 100%. The deactivation rate constants, K and the half-life time, t½, 
were calculated using the following equation [25]: 
Half-life = 0.693/slope of the linear plot of log of the enzyme relative 
activity versus time of exposure, where deactivation rate constant (K) 
= slope of the straight line. 
Statistical analysis 
Data were expressed as mean values±standard deviation (SD). 
Statistical analysis was performed using the SPSS software (version 
22.0; IBM Corporation, Armonk, NY). The significance of differences 
between the mean values was determined by one-way analysis of 
variance (ANOVA) followed by Fisher LSD’s post hoc test, and a p 
values<0.05 were considered statistically significant. 
RESULTS AND DISCUSSION 
A partially purified preparation was attained by filtration of the 
broth to obtain a crude extract (specific activity 13.23U/mg protein). 
L-asp nanoemulsion was formulated employing oleic acid as oil, 
Tween 20/Tween 80 as surfactants and PG as co-surfactant. The 
optimized formulations were characterized via several methods, 
including droplet size, zeta potential determination and TEM. The 
efficiency of the enzyme nanoemulsion was evaluated according to 
different parameters, including the retained enzyme activity. 
Construction of phase diagrams 
The phase diagrams represent a significant part in considering the 
phase behavior of the developed nanoemulsions. For the 
construction of phase diagrams, oleic acid was employed as the oil 
phase, Tween 20/Tween 80 as surfactants and PG as co-surfactant. 
Fig. 1 reveals the constructed phase diagrams. Nanoemulsion areas 
(grey shaded areas) represent clear isotropic systems. The results 
showed that using either Tween 20 or Tween 80 as surfactant and 
PG as cosurfactant at Smix ratio (1:1), a transparent isotropic 
nanoemulsion was formed employing not more than 20 % oil. 
  
 
Fig. 1: Pseudoternary phase diagrams composed of oleic acid (oil), water and (a) Tween 20: PG (b) Tween 80: PG at Smix ratio 1:1, showing 
the clear o/w nanoemulsion region as grey shaded regions 
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Thermodynamic stability testing  
To check the stability of the selected NEs, the formulations were 
exposed to centrifugation study, heating and cooling cycle and 
freeze-thawing cycle to eliminate the metastable ones [26]. Table 1 
reveals that all investigated nanoemulsions passed all the 
thermodynamic studies performed. They were stable against 
centrifugation, heating cooling cycle as well as freeze-thaw cycles, 
without showing any phase separation, turbidity or coagulation. 
Thus, they were further subjected to dispersibility study.  
Dispersibility study 
Dispersibility study results, presented in table 1, revealed that the 
formulations containing 10% oil with either Tween 20 (F1) or 
Tween 80 (F4), succeeded to pass the dispersibility test. On the 
other hand, those containing 20% oil (F2 and F5) or 30% oil (F3 and 
F6) showed grades D or E, thus failed to pass the test and were 
eliminated from further studies. The results revealed that the 
increase in oil concentration (F2, F3, F5 and F6), needed more time 
for emulsification. This can be attributed to the high interfacial 
tension between the volume of oil and aqueous phase resulting in a 
net decrease in the surfactant system. This leads to longer 
emulsification time [23, 27]. Those formulations that passed the 
dispersibility test were subjected to further characterization. 
Characterization of L-asp NE 
Transmission electron microscopy  
The micrograph of L-asp nanoemulsion, presented in fig. 2, show 
that the nanoemulsion droplets exhibited spherical morphology.  
Droplet size and PDI 
Smaller droplet size lead to larger interfacial surface tension and 
may result in rapid absorption and improvement of the drug 
bioavailability [18]. The results of droplet size and PDI 
measurement are tabulated in table 2. The mean droplet size 
diameters were 85.45±20.54 nm and 70.89±15.37 nm for the 
optimized NEs; F1 and F4, respectively. These results confirmed that 
the developed NE formulations were in the nanometric dimensions 
(<100 nm). It could be concluded that NE developed using Tween 80 
as a surfactant exhibited comparatively smaller droplets. This can be 
attributed to the fact that nonpolar tail in Tween20 is saturated and 
linear, while that of Tween80 is unsaturated and twisted. This 
emphasizes the importance of studying the molecular geometry of 
non-ionic surfactants on NE droplet size [19]. PDI values were less 
than 0.5, indicating high uniformity of droplet size [28, 29]. 
 
 
Fig. 2: TEM micrograph of selected L-asp loaded NE 
  
Table 2: Droplet size, PDI and zeta potential of L-Asp loaded NEs 
Formulation Droplet size (nm±SD) PDI  Zeta potential (mV±SD) 
F1 85.45±20.54 0.241±0.13 -21.3±2.63 
F4 70.89±15.37 0.279±0.08 -32.5±7.76 
Results are presented as mean±SD (n=3). 
 
Zeta potential 
ZP is considered to give an indication on the physical stability of the 
developed nanoemulsion. Results of ZP of optimized L-asp loaded 
nanoemulsions are shown in table 2. High zeta potential values of 
the prepared nanoemulsion is required to generate an energy 
barrier that works against coalescence of the dispersed droplets 
[30]. ZP values of F1 and F4 nanoemulsions were-21.3±2.63 mV and-
32.5±7.76 mV, respectively, revealing stable systems and good 
separation of emulsion globules [31]. It can be observed that Tween 
80 nanoemulsion (F4) showed higher negatively charged ZP values 
when compared to Tween 20 nanoemulsion (F1), indicating higher 
stability of Tween 80 NE. 
Optimization of enzyme loading 
In order to compare the enzyme activity of L-asp loaded NE, namely 
F1 and F4, composed of Tween 20 and Tween 80, respectively, they 
were loaded with different concentrations of L-asp. The effect of 
different concentrations of L-asp on its activity after being 
incorporated in NE are shown in fig. 3. The results revealed that L-
asp nanoemulsion F4 (Tween 80 NE) loaded with protein (10% v/v) 
showed statistically higher (p<0.05) enzymatic activity [323 U/ml], 
when compared to the F1 (Tween 20 NE) loaded with the same 
amount of protein [197 U/ml]. Tween 80 possesses an oleate-chain 
with 18 carbon atoms and one unsaturated bond. It leads to a more 
stable O/W interface layer and subsequently to higher emulsion 
stability. On the other hand, Tween 20 has saturated laurate-chains 
with only 12 carbon atoms. In addition, Tween 20 has a considerably 
higher HLB value than Tween 80; consequently, the differences in 
emulsion properties are easily conceivable [32]. Smaller droplet size 
(70.89+15.37 nm) of Tween80 lead to larger interfacial surface 
tension and may result in rapid absorption and improvement of the 
enzyme [33]. On the other hand, the L-asp nanoemulsion F4 loaded 
with 15 % (v/v) of protein showed a decrease in enzymatic activity 
(164U/ml). This drop in the specific activity after nano-
immobilization could be explained by the fact that when the amount 
of enzyme bounded increased, too many layers of enzymes have 
been loaded on the nanoemulsion, and thus the surface layer 
prevented contact between the substrate and enzymes in lower 
layers. 
Biochemical properties of the free and the immobilized L-asp 
Two different buffers, namely 0.1 M citrate phosphate buffer (pH 
5–7) and 0.1 M Tris (hydroxymethyl) amino methane buffer (pH 
8–9), were used to evaluate the effect of different pHs (5-9) of the 
reaction medium on the specific enzyme activity of L-asp 
nanoemulsion. The pH profile, shown in fig. 4, reveals that after L-
asp nano-immobilization, the optimum pH of the L-asp 
nanoemulsion exhibited an alkaline shift (pH 8–8.5). Generally, 
polycationic agents supports binding to enzymes, which results in 
shifting optimum pH value to alkaline ones [34]. Different 
variations of the free and immobilized L-asp nanoemulsion 
residual activity revealed that the native L-asp preparations 
exhibited maximum relative activity at pH 8.0. These data come in 
accordance with El-Hadi et al. (2019) [16]. As compared with free 
L-asp, the nanosized immobilized L-asp was more stable in the pH 
range from 8 to 8.5. This indicates that the stability of L-asp is 
improved by immobilization in the alkaline region. These results 
agree with that of Dias et al. (2016), who found that L-asp from A. 
oryzae CCT 3940 exhibited optimum activity at pH 8.0 [35]. Similar 
results were documented by earlier researchers working on 
Penicillium brevicompactum NRC 829 [36] and Streptomyces sp. 
[37]. Furthermore, these results agree with Meghavarnam et al. 
(2015) [25], who revealed that L-asp from Fusarium culmorum 
ASP-87 was active over a broad range of pH, being optimum at pH 
8.0. 
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Fig. 3: Effect of different concentrations of L-asp on its activity after its incorporation in nanoemulsion prepared using either tween 20 or 
tween 80. Data are expressed as mean±SD (n=3) 
 
 
Fig. 4: Effect of assay pH on free and immobilized enzyme. Data are expressed as mean±SD (n=3) 
 
The effect of assay temperature on the free and immobilized 
enzyme is demonstrated in fig. 5. The optimum reaction 
temperature for maximal activity was apparently shifted to 45 °C 
for the free nanoemulsion enzyme. Similar results were obtained 
by Muharram et al. (2014) who found that the optimal 
temperature from a thermotolerant strain E. coli KH027 in E. coli 
DH5α was 43 °C [38]. The wild L-asp from Cladosporium sp. 
exhibited an optimum temperature and pH of 30 °C and 6.3, 
respectively [39]. Low L-asp activity observed at higher 
temperatures may be attributed to partial denaturation [40]. The 
nano-immobilized enzyme preserved about 59.11±6.58 % of its 
residual activity at 50 °C; while, free L-asp preserved about 
33.84±4.54 % of its activity at the temperature of 50 °C. This 
stabilization at high temperatures could be explained by the 
protection of the enzyme against the environment alterations 
due to its incorporation in the nanoemulsion. The activation 
energy of the immobilized enzyme (1.99 Kcal/mol) was lower 
than that of the free one (2.93 Kcal/mol). 
 
 
Fig. 5: Effect of assay temperature on free and immobilized enzyme. Data are expressed as mean±SD (n=3) 
Mohsen et al. 
Int J App Pharm, Vol 12, Issue 5, 2020, 203-210 
208 
Thermal stability of the nano-immobilized Streptomyces L-asp 
Thermal stability of free and immobilized L-asp residual activities is 
shown in fig. 6 and 7, respectively. The free enzyme exhibited a half-
life of 2.88 h, 2.4 h, and 2.16 h at 50, 55 and 60 °C, respectively. This 
comes in accordance with Kumar et al. (2005) who studied the half-
life of Bacillus coagulans BTS3 lipase, which was shown to be 2 h at 
55 °C [41]. Protection of the enzymes can occur by immobilization 
processes. The half-life values of immobilized enzyme at 50, 55, and 
60 °C were 346.5, 259.87, and 148.5 min, respectively, which are 
higher than those of the free enzyme (173.25, 148.5, 129.93 min), 
respectively, at the same temperatures. Full activation up to 45 °C 
was achieved when L-asp was immobilized on NE. These results are 
similar to those obtained by Huang et al. (2014) who found that 
binary immobilized L-asp of Candida rugosa, at 40 °C, was 
completely active [42]. However, inactivation of the enzyme 
occurred on treatment at higher temperatures. Upon exposure to 60 
°C for 1 h, free L-asp preserved about 60% of its residual activity, 
while it’s immobilized one preserved about 76% of its residual 
activity. The thermostability of the free enzyme of Rhizopus oryzae 
was studied by Hiol et al. (2000) [43] who revealed inactivation at 
45 °C and complete loss of activity at 50 °C after a 40 min incubation. 
This thermal stabilization could be explained by the incorporation of 
L-asp in nanoemulsion, thus the enzyme was fully protected against 
environmental alterations. The inactivation temperature of the free 
and immobilized L-asp was observed to be between 50 and 60 °C. 
Nguyen et al. reported that earlier reports on the thermostability of 
different L-asp preparations indicated that the native enzymes were 
unstable at high temperatures [44]. 
  
 
Fig. 6: Log of relative activity retained as a function of time for the free enzyme. Data are expressed as mean±SD (n=3) 
 
 
Fig. 7: Log of relative activity retained as a function of time for the immobilized L-asp enzyme. Data are expressed as mean±SD (n=3)
 
The deactivation rate constants of the immobilized L-asp for the 
temperatures of 50, 55 and 60 °C, were 2x10–3, 2.66x10–3, and 
4.66x10–3 respectively. These constants were lower than those of 
the free enzyme (4x10–3, 4.66x10–3and 5.33x10-3) at the same 
temperatures. Similar results were obtained by Asker et al. (2012) 
[45] who found that the immobilized asparaginase enzyme, obtained 
from Pseudomonas aeruginosa 50071, was more stable than the free 
enzyme where the deactivation rate constant at 50 °C for alginate 
immobilized L-asp was (2.82 ×10-2), which was significantly lower 
than that of the free asparaginase enzyme (6.72 × 10-2). 
CONCLUSION 
L-asp loaded NE was successfully developed and characterized. It 
was observed that Tween 80 NE (F4) showed significantly smaller 
droplet size and higher negatively charged ZP values than Tween 20 
NE (F1), indicating higher stability of Tween 80 NE. The pH and 
Mohsen et al. 
Int J App Pharm, Vol 12, Issue 5, 2020, 203-210 
209 
thermal stability and half-life of L-asp were evaluated. The 
immobilized enzyme was more resistant to alkaline pH (8-8.5) and 
to high temperatures as compared to the free one. Upon comparing 
the thermal stability of free and immobilized L-asp residual 
activities at 60 °C for 1 h, the results revealed that free L-asp 
preserved about 60% of its residual activity, while its immobilized 
one preserved about 76% of its residual activity. L-asparaginase, 
obtained from Streptomyces griseoplanus, was more stable when 
incorporated in NE than the free enzyme where the deactivation rate 
constant at 50 °C was 2x10–3for immobilized L-asp which is lower 
than that of the free asparaginase enzyme (4x10–3). These findings 
reveal that the incorporation of L-asp in nanoemulsion effectively 
enhanced the activity of L-asp. Thus, it can be concluded that 
nanoemulsion could be a potential drug delivery system for 
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